share_log
Reuters ·  Mar 17 11:05
Travere Therapeutics Inc: Plans to Submit Amendment to Rems Snda Currently Under Review for Modification of Liver Monitoring
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 216

Recommended

Write a comment